ANNUAL REPORT OF THE NATIONAL CANCER REGISTRY BOARD IN ACCORDANCE WITH SECTION 22 OF THE PROTECTED DISCLOSURES ACT 2014 (AS AMENDED)
This report under Section 22 of the Protected Disclosures Act 2014 (as amended) (the “Act”) covers the period from 1 January 2023 to 31 December 2023.
The National Cancer Registry Board has established internal reporting channels and procedures in accordance with the Act which are detailed in its Protected Disclosures Policy.
No protected disclosures were made to the National Cancer Registry Board under the Act during the period covered by this report. There are no open investigations or proceedings in respect of protected disclosures relating to the years preceding the period covered by this report.
Printer-friendly version
